{"schema_version":"1","generated_at":"2026-11-21T20:49:03.921Z","data_as_of":null,"url":"https://www.findmykol.com/kol/john-bernardo","json_url":"https://www.findmykol.com/kol/john-bernardo/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"john-bernardo","name":"John Bernardo","credential":"MD","specialty":"Pulmonary Disease","specialty_raw":"Pulmonary Disease","therapeutic_area":"Respiratory","therapeutic_areas":["Respiratory"],"institution":"Boston University","institution_url":"https://www.findmykol.com/institution/boston-university","city":"Boston","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"John Bernardo is a Respiratory physician affiliated with Boston University. OpenAlex indexes 85 publications with 3,779 citations (h-index 28).","overview":null,"focus":{"indications":[],"research_topics":["Respiratory"]},"scholarship":{"works_count":85,"cited_by_count":3779,"h_index":28,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Viatris Specialty LLC","program_year":2025,"amount_usd":23.54,"payment_count":1},{"payer":"Stryker Corporation","program_year":2025,"amount_usd":19.68,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":2,"areas_shown":2,"areas":[{"area":"Respiratory","share_pct":93.6,"classes_total":6,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":32.2,"drugs":[{"name":"Fluticasone Propionate","share_pct":56.9},{"name":"Flovent Hfa","share_pct":43.1}],"max_beneficiaries":null},{"class":"beta2-Adrenergic Agonist","setting":"prescribed","share_pct":21.8,"drugs":[{"name":"Albuterol Sulfate Hfa","share_pct":70.5},{"name":"Ventolin Hfa","share_pct":29.5}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":6.4,"classes_total":1,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":6.4,"drugs":[{"name":"Omeprazole","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":2,"fiscal_years":{"first":1992,"last":2000},"rows_total":9,"shown":3,"withheld":6,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K07HL003035","title":"TUBERCULOSIS TRAINING PROGRAM--BOSTON","fiscal_year":2000,"amount_usd":"100100","organization":"BOSTON UNIVERSITY MEDICAL CAMPUS","source_url":"https://reporter.nih.gov/quickSearch/K07HL003035"},{"project":"K07HL003035","title":"TUBERCULOSIS TRAINING PROGRAM--BOSTON","fiscal_year":1999,"organization":"BOSTON UNIVERSITY MEDICAL CAMPUS","source_url":"https://reporter.nih.gov/quickSearch/K07HL003035"},{"project":"K07HL003035","title":"TUBERCULOSIS TRAINING PROGRAM--BOSTON","fiscal_year":1998,"organization":"BOSTON UNIVERSITY MEDICAL CAMPUS","source_url":"https://reporter.nih.gov/quickSearch/K07HL003035"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease","year":2023,"journal":"Clinical Infectious Diseases","source_url":"https://doi.org/10.1093/cid/ciad312","status":"verified"},{"title":"E-cigarette, or vaping, product use-associated lung injury: a review","year":2020,"journal":"Pneumonia","source_url":"https://doi.org/10.1186/s41479-020-00075-2","status":"verified"},{"title":"A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies","year":2017,"journal":"American Journal of Respiratory and Critical Care Medicine","source_url":"https://doi.org/10.1164/rccm.201705-0926oc","status":"verified"},{"title":"Acute-Phase Deaths from Murine Polymicrobial Sepsis Are Characterized by Innate Immune Suppression Rather Than Exhaustion","year":2015,"journal":"The Journal of Immunology","source_url":"https://doi.org/10.4049/jimmunol.1500874","status":"verified"},{"title":"The Health-System Benefits and Cost-effectiveness of Using Mycobacterium Tuberculosis Direct Nucleic Acid Amplification Testing to Diagnose Tuberculosis Disease in the United States","year":2013,"journal":"Clinical Infectious Diseases","source_url":"https://doi.org/10.1093/cid/cit336","status":"verified"}],"source":"works"},"similar":[{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Gary Balady","slug":"gary-balady","institution":"Boston University","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/gary-balady","json_url":"https://www.findmykol.com/kol/gary-balady/profile.json"},{"name":"Andrew Budson","slug":"andrew-budson","institution":"Boston University","specialty":"Neurology","url":"https://www.findmykol.com/kol/andrew-budson","json_url":"https://www.findmykol.com/kol/andrew-budson/profile.json"},{"name":"Jeffrey Samet","slug":"jeffrey-samet","institution":"Boston University","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/jeffrey-samet","json_url":"https://www.findmykol.com/kol/jeffrey-samet/profile.json"},{"name":"Justin Oldham","slug":"justin-oldham","institution":"University of Michigan","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/justin-oldham","json_url":"https://www.findmykol.com/kol/justin-oldham/profile.json"},{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"Ronald Crystal","slug":"ronald-crystal","institution":"Weill Cornell Medicine","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ronald-crystal","json_url":"https://www.findmykol.com/kol/ronald-crystal/profile.json"},{"name":"Bartolome Celli","slug":"bartolome-celli","institution":"Brigham and Women's Hospital","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/bartolome-celli","json_url":"https://www.findmykol.com/kol/bartolome-celli/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"funding":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}